Science Team
Sibah Hassan
Target Validation lead Scientist
Sibah graduated with a PhD in Life Science from the University of Lausanne, where he validated a new wake-promoting compound (FDA & EMA approved) using a pharmacogenomics approach. He has over 10 years of postdoctoral experience in Neuroscience research (Surrey and Oxford Universities) ranging from biomarker development (for Sleep and Circadian rhythms) to studying the effects of light in brain and behaviour. After finishing his postdoctoral research at the Department of Pharmacology (University of Oxford), working on septo-hippocampal oscillations, he joined Neuro-Bio as Senior Neuroscientist. Sibah is now working on both biomarkers and therapeutic approaches to tackle neurodegeneration, using in vitro model of AD to screen novel compounds at the cellular level, and understand their mode of action.
Lucy Granat
Senior Scientist
Dr Lucy Granat is a drug discovery scientist with experience in neuroscience, cell-based assay development and target validation. As Senior Scientist and Antisense Oligonucleotide (ASO) Project Lead at Neuro-Bio, Lucy leads an early-stage RNA-based therapeutics project. Previously, Lucy worked at the Alzheimer’s Research UK Drug Discovery Institute at UCL, developing assays and supporting small-molecule discovery programmes. Lucy holds a PhD in Neurobiology from King’s College London.